More study is needed to understand the relationship between the RUNX3's involvement in the tumor‐promoting ability and the association of this protein with good clinical outcome, from which we could seek for a possibility to focus on RUNX3 as a therapeutic target in the future. Here, RUNX3 is linked to neoplasm.